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Ovarian stem cells are always accompanied




Background: Existing dogma that a female is born with fixed number of eggs was challenged by the detection of
stem cells in adult mammalian ovary. Data has accumulated in support of ovarian stem cells (OSCs) proliferation,
maintenance in culture, formation of germ cell nests and differentiation into oocytes and primordial follicle
assembly using different strategies.
Results: Flow cytometry analysis identified >8 μm OSCs which are DDX1 positive and are considered
equivalent to spermatogonial stem cells (SSCs) in testis. Analysis of both ovarian and testicular smears obtained
after enzymatic digestion has led to the identification of an additional stem cell population termed very small
embryonic-like stem cells (VSELs). VSELs and OSCs/SSCs differ from each other in their size and OCT-4 expression.
VSELs express pluripotent markers including nuclear OCT-4 whereas OSCs/SSCs express cytoplasmic OCT-4
suggesting a differentiated state. VSELs can be studied by flow cytometry as small sized cells which are LIN-/
CD45-/Sca-1+. We have reported 0.02 ± 0.008, 0.03 ± 0.017 and 0.08 ± 0.03 % of total cells as VSELs in normal,
chemoablated and after FSH treatment to chemoablated mouse ovary.
Conclusions: VSELs have remained poorly studied till now because of their very small size and rare occurrence.
Spinning cells obtained after enzymatic digestion of ovarian tissue at a speed of 1000G (rather than 1200 rpm)
throughout processing allows reliable detection of the VSELs by flow cytometry. VSELs exist in aged, chemoablated
and non-functional ovary and providing a healthy niche to support their function offers an interesting strategy to
manage infertility.
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Commentary
We read with great interest a recent review in Journal
of Ovarian Research published by Silvestris et al. [1]
on ovarian stem cells and how they could be used to
manage infertility. They have described in a very lucid
manner how the research progressed in the field and
we thank them for confirming by flow cytometry that
indeed DDX-1 positive ovarian stem cells (OSCs) co-
express OCT-4. This confirms that the stem cells
isolated from ovarian cortical tissue by Tilly’s group by
flow cytometry [2] are similar to the OCT-4 positive
stem cells isolated by mechanical scraping of ovary
surface epithelium (OSE) by our group [3, 4]. This type of
third party confirmation and validation of presence of
stem cells in adult mammalian ovary is necessary to con-
vince the scientific community and bring about a para-
digm shift in the field of ovarian biology.
But we have shown the co-existence of two distinct
populations of stem cells in OSE including the ovary
germ stem cells (OGSCs) which are the same as OSCs
and a small sub-population of very small embryonic-like
stem cells (VSELs) [3, 4]. The basic difference between
the two populations is their size and OCT-4 expression
(Fig. 1). VSELs are 3–5 μm in size and express nuclear
OCT-4 whereas the OSCs are more than 8 μm in size
and express cytoplasmic OCT-4. It is well known that
nuclear OCT-4 is suggestive of pluripotent state of a
stem cell and it is no longer required once the stem cells
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start to differentiate [5]. On this basis we have postu-
lated that VSELs are the most primitive, pluripotent
stem cells in the ovary and give rise to committed
tissue-specific progenitors OSCs (express cytoplasmic
OCT-4 and other germ cell markers) [6]. VSELs are rela-
tively quiescent whereas the OSCs divide rapidly and
form germ cell nests prior to differentiating into oocytes.
Interestingly, we have also reported that ovarian stem
cells express receptors for follicle stimulating hormone
(FSH) and the process of asymmetric cell division (in-
cluding self-renewal and giving rise to OSCs) of VSELs
appears to be under the influence of FSH via alterna-
tively spliced growth factor type 1 receptor isoform
FSHR3 [7]. We have also reported similar VSELs in
Fig. 1 Two populations of stem cells (VSELs and OGSCs) in adult ovary. a H&E stained sheep OSE smear. Two distinct populations of stem cells
including VSELs (arrow) which are smaller than the red blood cells and slightly bigger OGSCs (asterix) are clearly visualized even after gently scraping
sheep ovary fixed overnight in neutral buffered formalin. Red blood cells and epithelial cells are also clearly visualized [4]. b (i-vi) Characterization of
ovarian stem cells using pluripotent markers OCT-4 and SSEA-4. Smaller VSELs express nuclear OCT-4 and cell surface SSEA-4 whereas slightly bigger
OGSCs express cytoplasmic OCT-4 and minimal SSEA-4. Note the VSELs do not stain with DAPI [3]. c (i) Sheep OSE smear immuno-stained with FSHR
antibody. Note epithelial cells are negative whereas the stem cells exhibit distinct positive stain. (ii) Confocal microcopy localization of FSHR on VSELs,
OGSCs and on a germ cell nest. (iii-iv) in situ hybridization of FSHR on ovarian stem cells after FSH treatment using oligoprobes specific for FSHR1 and
FSHR3 respectively. Note active transcription of FSHR3 mRNA in the cytoplasm of stem cells after FSH treatment whereas FSHR1 is expressed in the
stem cells and the expression is not affected by FSH treatment. d qRT-PCR analysis of FSHR1 and FSHR3 after 3 and 15 h of FSH treatment. Note that
only FSHR3 levels are increased transiently after 3 and return to basal levels by 15 h. c and d panels show earlier published data by Patel et al. [7].
Please refer to the cited references for further details
Bhartiya Journal of Ovarian Research  (2015) 8:70 Page 2 of 4
human and mouse testis [8, 9] and thus a similar popu-
lation of VSELs in the gonads gives rise to OSCs in
ovary and SSCs in testis.
The protocol discussed by Silvestris group picked up
only OSCs similar to earlier published data from Tilly’s
group. But flow cytometry on enzymatically isolated
mouse ovarian cells and taking care to spin at 1000G (as
being small in size, VSELs do not pellet at the usual
1200 rpm speed), we have reported the presence of LIN-/
CD45-/SCA-1+ VSELs in normal (0.02 ± 0.008 %) and
chemoablated (0.03 ± 0.017 %) adult mouse ovary [10].
Interestingly treating chemoablated mice with FSH re-
sulted in self-renewal of VSELs as judged by an increase
in their numbers by flow cytometry (0.08 ± 0.03 %), gave
rise to OSCs with cytoplasmic OCT-4, formed germ cell
nests and initiated differentiation into oocyte-like struc-
tures [10]. Using flow cytometry, Parte et al. [4] identified
two distinct populations of stem cells in sheep OSE in-
cluding VSELs (2–4 μm sized cells 1.26 ± 0.19 %) and
OGSCs (4–9 μm are 6.86 ± 0.5 %). Thus the protocols to
isolate OSCs published by Tilly’s group [2] and by Silves-
tris et al. [1] need to be modified to show that VSELs al-
ways accompany OSCs. A simple incorporation of
spinning cells (collected by enzymatic isolation) at 1000G
rather than the usual 1200 rpm during cell processing for
flow cytometry will enable anyone to validate our claims
of presence of VSELs in adult ovary.
Silvestris et al. [1] also discuss the earlier findings of
Tilly’s group [11] regarding presence of germ cell
markers (Oct4, MVH, Dazl, Stella, Fragilis) in bone
marrow of cyclophosphamide and busulphan treated
mice. Ratajczak’s group was the first to describe VSELs
in 2006 [12] and various groups have observed re-
cently that VSELs get mobilized [13–17] under stress
conditions when the function of any organ in the body
gets compromised. Germ cell markers in chemoab-
lated mice bone marrow were detected by Tilly’s group
[11] because VSELs were mobilized to reach the ovary
in order to bring about homeostasis after ovarian
function was compromised by cyclophosphamide and
busulphan treatment. Furthermore, fertility restoration in
chemoablated mice after BM transplantation is from the
endogenous VSELs which survive chemotherapy whereas
the transplanted BM only helps to improve the niche thus
explaining the observations of Niikura et al. [18] that trans-
planting GFP+ BM in chemoablated mice resulted in non-
GFP pups.
It is very true that protocols for the use of cryopre-
served cortical tissue for fertility preservation are not yet
perfect and a risk of re-introducing malignant cells ex-
ists. A total of 37 babies have been born by transplanting
cortical tissue in cancer survivors [19] and Demeestere
et al. [20] recently reported spontaneous pregnancy and
live-birth from ovarian cortical tissue cryopreserved for
more than a decade; but the true source of the oocytes
in these cases (whether it is the transplanted cortical
tissue or the non-functional ovary) that results in the ba-
bies is still not clear and has been recently discussed by
us [21]. Simultaneously, efforts are ongoing to differenti-
ate embryonic stem cells and induced pluripotent stem
cells into primordial germ cells in mice [22] as well as in
humans [23]. Obtaining PGCs from ES cells is crucial as
they exhibit an inherent potential to spontaneously dif-
ferentiate into oocytes [24]. While ES cells during the
course of development are obtained from inner cell mass
of developing blastocyst, PGCs are relatively mature and
arise from the epiblast stage embryo. ES cells and PGCs
basically differ from each other in their epigenetic status
since PGCs (during their migration along the dorsal
mesentery to reach the gonadal ridge) undergo erasure
of imprinted genes. It is very difficult to mimic this epi-
genetic maturity of PGCs in vitro starting with ES cells
and thus the roadblock in obtaining ‘synthetic gametes’
from hES cells to cure infertility. On the other hand,
VSELs are postulated to be equivalent to the PGCs and
we have reported that they spontaneously differentiate
into oocytes in vitro [3, 10] and also sperm [25]. This
understanding and better potential of VSELs over ES
cells to form gametes in vitro was recently discussed
[26] and needs to be appreciated by the scientific com-
munity. Vassena et al. [27] have also recently confused
between OSCs and VSELs.
For treating infertility–the million dollar question is
whether we need to treat and administer more stem cells
in the non-functional ovary or improve the microenvir-
onment for stem cells (that may be existing) to function
properly! Various groups have suggested that decline of
ovarian function with age is because the niche gets com-
promised and is unable to support stem cells differenti-
ation into oocytes. On transplanting stem cells from
aged ovary into a young ovary resulted in normal oo-
cytes formation [18]. We found stem cells in the ovarian
tissue obtained from a 60 years old woman which spon-
taneously differentiated into oocyte-like structures on
putting in culture (where unfavorable factors in vivo are
overcome). Similarly we have also reported that culture of
both (i) chemoablated intact mouse ovary and (ii) the OSE
cells obtained by enzymatic isolation results in spontan-
eous differentiation of oocyte-like structures [10]. Thus it
is only required to improve the microenvironment for
stem cells to function and thereby cure infertility, meno-
pause etc. Transplanting Sertoli cells and bone marrow
derived mesenchymal cells independently in chemoablated
testis restored spermatogenesis [9]. Many groups have
reported improved gonadal function and live pups by
transplanting mesenchymal cells from various sources into
chemoablated gonads. Caicki et al. [28] and Lai et al. [29]
transplanted mesenchymal cells expanded from adipose
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tissue and endometrium respectively into chemoablated
gonads and obtained live births. It is postulated that trans-
planted mesenchymal cells help improve the niche and
enable VSELs to regenerate chemoablated gonads.
To conclude, adult mammalian ovary harbors VSELs
and OSCs just like VSELs and SSCs in the testis. Endogen-
ous VSELs can be targeted to regenerate non-functional
gonads and thus offer an interesting alternative strategy to
cure infertility.
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